Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-06

Clinical Trial Update: Apatinib Treating Patients With Advanced Cervical Cancer After Radiotherapy and First-line Chemotherapy. [Phase 2]

View source ↗

Summary

Phase 2 trial exploring apatinib for advanced cervical cancer after radiotherapy and first-line chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Apatinib (apatinib)

Snippet

Sponsor: Anhui Provincial Hospital | Conditions: Cervical Cancer | Phase 2 | Status: UNKNOWN